Treatment of psoriasis with interleukin-10 [3]

Journal of Investigative Dermatology

Volumn 111, Issue 6, 1998, Pages 1235-1236

  Reich, K ^a   Bruck, M ^a   Grafe, A ^a   Vente, C ^a   Neumann, C ^a   Garbe, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

CELL FUNCTION; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE ACTIVATION;

EID: 0032458296     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00444.x     Document Type: Letter

References (11)

1. K. Asadullah W. Sterry K. Stephanek IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach J Clin Invest 101 1998 783 794
2. D.J. Berg M.W. Leach R. Kuhn K. Rajewsky W. Müller N.J. Davidson D. Rennick Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses J Exp Med 182 1995 99 108
3. S.L. Gottlieb P. Gilleudeau R. Johnson L. Estes T.G. Woodworth A.B. Gottlieb J.G. Krueger Response of psoriasis to a lymphocyte-selective toxin (DAB-389-IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nature Med 1 1995 442 447
4. K. Hoffmann T. Dirschka H. Schwarz S. el-Gammal U. Matthes A. Hoffmann P. Altmeyer 20 Mhz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgaris Dermatol Sci 9 1995 103 110
5. L. Li J.F. Elliot T.R. Mosmann IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity J Immunol 153 1994 3967 3978
6. R.S. Mitra T.A. Judge F.O. Nestle L.A. Turka B.J. Nickoloff Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7–1 (CD80) and B7–2 (CD86) expression J Immunol 154 1995 2668 2677
7. B.J. Nickoloff D.P. Fivenson S.L. Kunkel R.M. Strieter L.A. Turka Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques Clin Immunol Immunopathol 73 1994 63 68
8. J.F. Nicolas N. Chamchick J. Thiovolet J. Wijdenes P. Morel P. Revillard CD4 antibody treatment of severe psoriasis Lancet 338 1991 321
9. J.M. Rivas S.E. Ullrich Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratincyte-derived-IL-10 J Immunol 149 1992 3865 3866
10. K. Uyemura M. Yamamura D.F. Fivenson R.L. Modlin B.J. Nickoloff The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response J Invest Dermatol 101 1993 701 705
11. S.J. Van Deventer C.O. Elson R.N. Fedorak Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease Gastroenterology 113 1997 383 389